The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Press release from Business Wire

ARIAD to Present at Bank of America Merrill Lynch 2012 Health Care Conference

Thursday, May 10, 2012

ARIAD to Present at Bank of America Merrill Lynch 2012 Health Care Conference07:35 EDT Thursday, May 10, 2012 CAMBRIDGE, Mass. (Business Wire) -- ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that it will webcast its presentation at the Bank of America Merrill Lynch 2012 Health Care Conference in Las Vegas. Harvey J. Berger, M.D., chairman and chief executive officer, will provide an overview of the Company's business on Wednesday, May 16, 2012 at 9:20 a.m. (PT). The ARIAD presentation at the Bank of America Merrill Lynch 2012 Health Care Conference will be webcast live and can be accessed by visiting the investor relations section of the Company's website at http://www.ariad.com/investor. A replay of the webcast presentation will also be available and archived on the site for three weeks. About ARIAD ARIAD Pharmaceuticals, Inc. is an emerging global oncology company focused on the discovery, development and commercialization of medicines to transform the lives of cancer patients. ARIAD's approach to structure-based drug design has led to three internally discovered, molecularly targeted product candidates for drug-resistant or difficult-to-treat cancers, including certain forms of chronic myeloid leukemia, soft tissue and bone sarcomas and non-small cell lung cancer. For additional information, visit http://www.ariad.com or follow ARIAD on Twitter. ARIAD Pharmaceuticals, Inc.For InvestorsMaria E. Cantor, 617-621-2208Maria.cantor@ariad.comorFor MediaLynn Granito, 212-253-8881lgranito@berrypr.com